Rapid Diagnostics Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	168 Pages	Coherent Market Insights	May, 2023	CMI18001166

Best Price Guarantee
Price	from $4,500
Length	168 Pages
Publisher	Coherent Market Insights
Published Date	May, 2023
SKU	CMI18001166

Rapid Diagnostics Market, By Product (Consumables and Instruments/Analysers), By Prescription (Professional Diagnostics and At-Home/OTC-Based Testing), By Application (Blood Glucose Testing, Cardiometabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drug of Abuse Testing, and Pregnancy and Fertility/Ovulation Testing), By End User (Hospitals and Clinics, Laboratories, Individuals/Home Healthcare Settings, and Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Rapid diagnostic tests are easy-to-use tests that provide quick results, usually 30 in minutes or less. These are quick field tests that can be performed in under 30 minutes and detect the presence of a pathogen quickly and accurately. Rapid results enable healthcare professionals/workers to make informed decisions quickly and protect the lives of their patients at the community level.

Market Dynamics:

Rise in prevalence of infectious/chronic diseases, outbreak of COVID-19 (pandemic), rise in usage of point-of-care diagnostics, favorable government initiatives, and rising awareness among people regarding early diagnosis are major factors expected to boost growth of the global rapid diagnostics market during the forecast period.

For instance, in March 2022, Brain Chemistry Labs and Arlington Scientific teamed up to develop an easy-to-use rapid test kit. The rapid test kit will detect the presence of β-methylamino-L-Alanine (BMAA), a toxin present in cyanobacterial blooms, which causes a fatal paralytic disease called Amyotrophic Lateral Sclerosis (ALS).

Key features of the study:

This report provides in-depth analysis of the global rapid diagnostics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global rapid diagnostics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, and Ascensia Diabetes Care Holdings, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global rapid diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rapid diagnostics market.

Detailed Segmentation:

Global Rapid Diagnostics Market, By Product:

Consumables

Instruments/Analysers

Global Rapid Diagnostics Market, By Prescription:

Professional Diagnostics

At-Home/OTC-Based Testing

Global Rapid Diagnostics Market, By Application:

Blood Glucose Testing

Cardiometabolic Testing

Infectious Disease Testing

Blood Coagulation Testing

Hematology Testing

Cancer Testing

Drug of Abuse Testing

Pregnancy and Fertility/Ovulation Testing

Global Rapid Diagnostics Market, By End User:

Hospitals and Clinics

Laboratories

Individuals/Home Healthcare Settings

Others

By Geography:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Company Profiles:

Abbott

Danaher

Quidel

BD

LifeScan

Siemens Healthineers

F. Hoffmann-La Roche

Ascensia Diabetes Care Holdings

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Product; Market Snapshot, By Prescription; Market Snapshot By Application; Market Snapshot, By End User; Market Snapshot, By Geography; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Rise in prevalence of chronic/infectious disease; Stringent regulations and rapid diagnostics challenges; The outbreak of COVID-19 (global pandemic); Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Rapid Diagnostics Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Rapid Diagnostics Market, By Product, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; Consumables; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Instruments/Analysers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
6. Global Rapid Diagnostics Market, By Prescription, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; Professional Diagnostics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); At-Home/OTC-Based Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
7. Global Rapid Diagnostics Market, By Application, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; Blood Glucose Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Cardiometabolic Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Infectious Disease Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Blood Coagulation Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Hematology Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Cancer Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Drug of Abuse Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Pregnancy and Fertility/Ovulation Testing; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
8. Global Rapid Diagnostics Market, By End User, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; Hospitals and Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Laboratories; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Individuals/Home Healthcare Settings; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
9. Global Rapid Diagnostics Market, By Geography, 2017-2030, (US$ Bn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2017 - 2030; Segment Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn); 10. Competitive Landscape; Abbott; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Danaher; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Quidel; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; BD; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; LifeScan; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Siemens Healthineers; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; F. Hoffmann-La Roche; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Ascensia Diabetes Care Holdings; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Analyst Views; 11. Section; Research Methodology; About us; *Browse 24 market data tables and 28 figures on "Global Rapid Diagnostics Market” - forecast to 2030